TY - GEN AU - Graham,Ian AU - Atar,Dan AU - Borch-Johnsen,Knut AU - Boysen,Gudrun AU - Burell,Gunilla AU - Cifkova,Renata AU - Dallongeville,Jean AU - De Backer,Guy AU - Ebrahim,Shah AU - Gjelsvik,Bjørn AU - Herrmann-Lingen,Christoph AU - Hoes,Arno AU - Humphries,Steve AU - Knapton,Mike AU - Perk,Joep AU - Priori,Silvia G AU - Pyorala,Kalevi AU - Reiner,Zeljko AU - Ruilope,Luis AU - Sans-Menendez,Susana AU - Op Reimer,Wilma Scholte AU - Weissberg,Peter AU - Wood,David AU - Yarnell,John AU - Zamorano,Jose Luis AU - Walma,Edmond AU - Fitzgerald,Tony AU - Cooney,Marie Therese AU - Dudina,Alexandra AU - Vahanian,Alec AU - Camm,John AU - De Caterina,Raffaele AU - Dean,Veronica AU - Dickstein,Kenneth AU - Funck-Brentano,Christian AU - Filippatos,Gerasimos AU - Hellemans,Irene AU - Kristensen,Steen Dalby AU - McGregor,Keith AU - Sechtem,Udo AU - Silber,Sigmund AU - Tendera,Michal AU - Widimsky,Petr AU - Zamorano,Jóse Luis AU - Altiner,Attila AU - Bonora,Enzo AU - Durrington,Paul N AU - Fagard,Robert AU - Giampaoli,Simona AU - Hemingway,Harry AU - Hakansson,Jan AU - Kjeldsen,Sverre Erik AU - Larsen,mogens Lytken AU - Mancia,Giuseppe AU - Manolis,Athanasios J AU - Orth-Gomer,Kristina AU - Pedersen,Terje AU - Rayner,Mike AU - Ryden,Lars AU - Sammut,Mario AU - Schneiderman,Neil AU - Stalenhoef,Anton F AU - Tokgözoglu,Lale AU - Wiklund,Olov AU - Zampelas,Antonis TI - European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) SN - 1741-8267 PY - 2007///1120 KW - Blood Pressure KW - drug effects KW - Cardiovascular Agents KW - pharmacology KW - Cardiovascular Diseases KW - blood KW - Diabetes Mellitus KW - Dyslipidemias KW - Female KW - Genetic Predisposition to Disease KW - Guideline Adherence KW - Health Promotion KW - Heart Rate KW - Humans KW - Hypertension KW - complications KW - Hypoglycemic Agents KW - therapeutic use KW - Hypolipidemic Agents KW - Inflammation KW - Kidney Diseases KW - Life Style KW - Lipids KW - Male KW - Metabolic Syndrome KW - Motor Activity KW - Nutritional Physiological Phenomena KW - Obesity KW - Overweight KW - Primary Prevention KW - standards KW - Risk Assessment KW - Risk Factors KW - Sex Factors KW - Smoking KW - adverse effects KW - Smoking Cessation KW - Stress, Psychological KW - Treatment Outcome N1 - Publication Type: Consensus Development Conference; Journal Article; Practice Guideline UR - https://doi.org/10.1097/01.hjr.0000277983.23934.c9 ER -